Literature DB >> 18519724

Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene.

Adeline Achard1, Véronique Guérin-Faublée, Vianney Pichereau, Corinne Villers, Roland Leclercq.   

Abstract

Streptococcus uberis UCN60 was resistant to spiramycin (MIC = 8 microg/ml) but susceptible to erythromycin (MIC = 0.06 microg/ml), azithromycin (MIC = 0.12 microg/ml), josamycin (MIC = 0.25 microg/ml), and tylosin (MIC = 0.5 microg/ml). A 2.5-kb HindIII fragment was cloned from S. uberis UCN60 DNA on plasmid pUC18 and introduced into Escherichia coli AG100A, where it conferred resistance to spiramycin by inactivation. The sequence analysis of the fragment showed the presence of an rdmC-like gene that putatively encoded a protein belonging to the alpha/beta hydrolase family and of the first 196 nucleotides of the mph(B) gene putatively encoding a phosphotransferase known to inactivate 14-, 15-, and 16-membered macrolides in E. coli. The entire mph(B) gene was then identified in S. uberis UCN60. The two genes were expressed alone or in combination in E. coli, Staphylococcus aureus, and Enterococcus faecalis. Analysis of MICs revealed that rdmC-like alone did not confer resistance to erythromycin, tylosin, and josamycin in those three hosts. It conferred resistance to spiramycin in E. coli and E. faecalis but not in S. aureus. mph(B) conferred resistance in E. coli to erythromycin, tylosin, josamycin, and spiramycin but only low levels of resistance in E. faecalis and S. aureus to spiramycin (MIC = 8 microg/ml). The combination of mph(B) and rdmC-like genes resulted in a resistance to spiramycin and tylosin in the three hosts that significantly exceeded the mere addition of the resistance levels conferred by each resistance mechanism alone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519724      PMCID: PMC2493112          DOI: 10.1128/AAC.00481-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 2.  Macrolide resistance conferred by base substitutions in 23S rRNA.

Authors:  B Vester; S Douthwaite
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  A transposon carrying the gene mphB for macrolide 2'-phosphotransferase II.

Authors:  N Noguchi; J Katayama; M Sasatsu
Journal:  FEMS Microbiol Lett       Date:  2000-11-15       Impact factor: 2.742

4.  Resistance phenotypes conferred by macrolide phosphotransferases.

Authors:  Olivier Chesneau; Krassimira Tsvetkova; Patrice Courvalin
Journal:  FEMS Microbiol Lett       Date:  2007-02-16       Impact factor: 2.742

Review 5.  Mastitis therapy and pharmacology.

Authors:  Ronald J Erskine; Sarah Wagner; Fred J DeGraves
Journal:  Vet Clin North Am Food Anim Pract       Date:  2003-03       Impact factor: 3.357

Review 6.  Macrolide antibiotics: binding site, mechanism of action, resistance.

Authors:  Marne Gaynor; Alexander S Mankin
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

7.  Aetiology of clinical mastitis in six Somerset dairy herds.

Authors:  A J Bradley; M J Green
Journal:  Vet Rec       Date:  2001-06-02       Impact factor: 2.695

8.  Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.

Authors:  R Leclercq; C Carlier; J Duval; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

9.  The hyaluronic acid capsule of Streptococcus uberis is not required for the development of infection and clinical mastitis.

Authors:  Terence R Field; Philip N Ward; Lars H Pedersen; James A Leigh
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  The role of histidine residues conserved in the putative ATP-binding region of macrolide 2'-phosphotransferase II.

Authors:  Kazuo Taniguchi; Akio Nakamura; Kazue Tsurubuchi; Koji O'Hara; Tetsuo Sawai
Journal:  FEMS Microbiol Lett       Date:  2004-03-19       Impact factor: 2.742

View more
  7 in total

Review 1.  Genetic elements responsible for erythromycin resistance in streptococci.

Authors:  Pietro E Varaldo; Maria Pia Montanari; Eleonora Giovanetti
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

Review 2.  The TetR family of regulators.

Authors:  Leslie Cuthbertson; Justin R Nodwell
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

3.  Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru).

Authors:  Angela Lluque; Susan Mosquito; Cláudia Gomes; Maribel Riveros; David Durand; Drake H Tilley; María Bernal; Ana Prada; Theresa J Ochoa; Joaquim Ruiz
Journal:  Int J Med Microbiol       Date:  2015-05-04       Impact factor: 3.473

4.  Presence and distribution of Macrolides-Lincosamide-Streptogramin resistance genes and potential indicator ARGs in the university ponds in Guangzhou, China.

Authors:  Mianzhi Wang; Jing Sun; Weixin Zhong; Wenguang Xiong; Zhenling Zeng; Yongxue Sun
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-30       Impact factor: 4.223

5.  Characterization of a multiresistant mosaic plasmid from a fish farm Sediment Exiguobacterium sp. isolate reveals aggregation of functional clinic-associated antibiotic resistance genes.

Authors:  Jing Yang; Chao Wang; Jinyu Wu; Li Liu; Gang Zhang; Jie Feng
Journal:  Appl Environ Microbiol       Date:  2013-12-20       Impact factor: 4.792

6.  Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular Infection Report.

Authors:  Raul Velez-Montoya; Dulce Rascón-Vargas; William F Mieler; Jans Fromow-Guerra; Virgilio Morales-Cantón
Journal:  J Ophthalmol       Date:  2010-07-14       Impact factor: 1.909

7.  The prevalence of genotypes that determine resistance to macrolides, lincosamides, and streptogramins B compared with spiramycin susceptibility among erythromycin-resistant Staphylococcus epidermidis.

Authors:  Marek Juda; Beata Chudzik-Rzad; Anna Malm
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03       Impact factor: 2.743

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.